Department of Emergency Medicine, Mayo Clinic, Rochester, MN 55905, USA.
J Allergy Clin Immunol. 2012 Mar;129(3):748-52. doi: 10.1016/j.jaci.2011.09.030. Epub 2011 Nov 1.
Diagnostic criteria were proposed at the Second Symposium on the Definition and Management of Anaphylaxis convened by the National Institute of Allergy and Infectious Diseases/Food Allergy and Anaphylaxis Network (NIAID/FAAN). Validation is needed before these criteria can be widely adapted into clinical practice.
Our aim was to retrospectively assess the diagnostic accuracy of the NIAID/FAAN criteria for the diagnosis of anaphylaxis in emergency department (ED) patients.
A retrospective cohort study of ED patients presenting from April to October 2008 was conducted. Patients given a diagnosis of an allergic reaction or anaphylaxis and a subset of patients with related diagnoses were included. Electronic medical records were reviewed and data were abstracted to determine whether the NIAID/FAAN criteria were met. Records were also independently reviewed in a blinded fashion by 2 experienced attending allergists. Final diagnosis by allergists was considered the reference standard.
Of 214 patients, 86 (40.2%) met the NIAID/FAAN criteria for anaphylaxis. Allergists gave 61 (28.5%) patients diagnoses of anaphylaxis, 59 (96.7%) of whom satisfied the NIAID/FAAN criteria. The interrater agreement between allergists was substantial (κ = 0.77). The test characteristics of the NIAID/FAAN criteria were as follows: sensitivity, 96.7% (95% CI, 88.8% to 99.1%); specificity, 82.4% (95% CI, 75.5% to 87.6%); positive predictive value, 68.6% (95% CI, 58.2% to 77.4%); negative predictive value, 98.4% (95% CI, 94.5% to 99.6%); positive likelihood ratio, 5.48; and negative likelihood ratio, 0.04.
These results suggest that the NIAID/FAAN criteria are highly sensitive but less specific and are likely to be useful in the ED for the diagnosis of anaphylaxis.
过敏反应和过敏性休克诊断标准是由美国国立过敏和传染病研究所/食物过敏和过敏性休克网络(NIAID/FAAN)第二次定义和管理过敏反应研讨会提出的。在这些标准被广泛应用于临床实践之前,需要对其进行验证。
本研究旨在回顾性评估 NIAID/FAAN 标准在急诊科(ED)患者诊断过敏反应中的诊断准确性。
对 2008 年 4 月至 10 月期间就诊于 ED 的患者进行回顾性队列研究。入组患者被诊断为过敏反应或过敏反应,以及具有相关诊断的亚组患者。审查电子病历并提取数据以确定是否符合 NIAID/FAAN 标准。病历还由 2 位经验丰富的主治过敏症医生进行独立盲法审查。过敏症医生的最终诊断被视为参考标准。
在 214 例患者中,86 例(40.2%)符合 NIAID/FAAN 诊断过敏反应的标准。过敏症医生诊断 61 例(28.5%)患者为过敏反应,其中 59 例(96.7%)符合 NIAID/FAAN 标准。过敏症医生之间的一致性很高(κ=0.77)。NIAID/FAAN 标准的测试特征如下:敏感性为 96.7%(95%CI,88.8%至 99.1%);特异性为 82.4%(95%CI,75.5%至 87.6%);阳性预测值为 68.6%(95%CI,58.2%至 77.4%);阴性预测值为 98.4%(95%CI,94.5%至 99.6%);阳性似然比为 5.48;阴性似然比为 0.04。
这些结果表明,NIAID/FAAN 标准具有很高的敏感性,但特异性较低,可能有助于急诊科诊断过敏反应。